Bruker Daltonik has been awarded US Patent No. 9,164,098, "Determining an expression status of human epidermal growth factor receptor 2 (HER2) in a biological sample."
Sometimes genetic tests give inconclusive results and provide little reassurance to patients, the Associated Press reports.
Vox wonders whether gene-editing crops will be viewed similarly as genetically modified organisms of if people will give them a try.
In Science this week: research regulation and reporting requirement reform, and more.
NPR reports that government and private insurers are being slow to cover recently approved CAR-T cell therapies.
This webinar will discuss an automated, high-throughput method of generating high-quality antigens and antibodies.